Local abaloparatide administration promotes in situ alveolar bone augmentation via FAK-mediated periosteal osteogenesis

Abstract

Insufficient alveolar bone thickness increases the risk of periodontal dehiscence and fenestration, especially in orthodontic tooth movement. Abaloparatide (ABL), a synthetic analog of human PTHrP (1–34) and a clinical medication for treating osteoporosis, has recently demonstrated its potential in enhancing craniofacial bone formation. Herein, we show that intraoral submucosal injection of ABL, when combined with mechanical force, promotes in situ alveolar bone thickening. The newly formed bone is primarily located outside the original compact bone, implying its origin from the periosteum. RNA sequencing of the alveolar bone tissue revealed that the focal adhesion (FA) pathway potentially mediates this bioprocess. Local injection of ABL alone enhances cell proliferation, collagen synthesis, and phosphorylation of focal adhesion kinase (FAK) in the alveolar periosteum; when ABL is combined with mechanical force, the FAK expression is upregulated, in line with the accomplishment of the ossification. In vitro, ABL enhances proliferation, migration, and FAK phosphorylation in periosteal stem cells. Furthermore, the pro-osteogenic effects of ABL on alveolar bone are entirely blocked when FAK activity is inhibited by a specific inhibitor. In summary, abaloparatide combined with mechanical force promotes alveolar bone formation via FAK-mediated periosteal osteogenesis. Thus, we have introduced a promising therapeutic approach for drug-induced in situ alveolar bone augmentation, which may prevent or repair the detrimental periodontal dehiscence, holding significant potential in dentistry.

References

[1] SalhotraA, ShahHN, LeviB, LongakerMT. Mechanisms of bone development and repair. Nat. Rev. Mol. Cell Biol., 2020, 21: 696-711.

[2] LiY, ZhanQ, BaoM, YiJ, LiY. Biomechanical and biological responses of periodontium in orthodontic tooth movement: up-date in a new decade. Int. J. Oral. Sci., 2021, 1320.

[3] NakaiY, PraneetpongN, OnoW, OnoN. Mechanisms of osteoclastogenesis in orthodontic tooth movement and orthodontically induced tooth root resorption. J. Bone Metab., 2023, 30: 297-310.

[4] KovacsCS, et al.. The role of biomineralization in disorders of skeletal development and tooth formation. Nat. Rev. Endocrinol., 2021, 17: 336-349.

[5] MizuhashiK, et al.. Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature, 2018, 563: 254-258.

[6] CuiC, et al.. Role of PTH1R signaling in Prx1(+) mesenchymal progenitors during eruption. J. Dent. Res., 2020, 99: 1296-1305.

[7] LiY, et al.. Expression of osteoclastogenesis inducers in a tissue model of periodontal ligament under compression. J. Dent. Res., 2011, 90: 115-120.

[8] MarinoS, BellidoT. PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus. Nat. Rev. Endocrinol., 2024, 20: 661-672.

[9] HattersleyG, DeanT, CorbinBA, BaharH, GardellaTJ. Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology, 2016, 157: 141-149.

[10] BhattacharyyaS, PalS, ChattopadhyayN. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide. Biochem. Pharma, 2019, 166: 185-191.

[11] ReidIR, BillingtonEO. Drug therapy for osteoporosis in older adults. Lancet, 2022, 399: 1080-1092.

[12] MillerPD, et al.. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA, 2016, 316: 722-733.

[13] MarinoS, et al.. Reversal of the diabetic bone signature with anabolic therapies in mice. Bone Res., 2023, 1119.

[14] LiY, et al.. Abaloparatide outperforms teriparatide in protecting against alveolar bone loss in experimental periodontitis. J. Periodontol., 2023, 94: 244-255.

[15] TanB, et al.. Biodegradable nanoflowers with abaloparatide spatiotemporal management of functional alveolar bone regeneration. Nano Lett., 2024, 24: 2619-2628.

[16] LatimerJ, et al.. Abaloparatide Enhances bone regeneration in extraction socket dental implant defects: an experimental in vivo study. Clin. Oral. Implants Res., 2025, 36: 471-480.

[17] XuL, et al.. Zinc finger-inspired peptide-metal-phenolic nanointerface enhances bone-implant integration under bacterial infection microenvironment through immune modulation and osteogenesis promotion. Bioact. Mater., 2024, 41: 564-576

[18] WangR, et al.. Abaloparatide and teriparatide enhance mandibular growth in adolescent rats with site-specific and mechano-related effects. Eur. J. Orthod., 2023, 45: 224-234.

[19] EvangelistaK, et al.. Dehiscence and fenestration in patients with Class I and Class II Division 1 malocclusion assessed with cone-beam computed tomography. Am. J. Orthod. Dentofac. Orthop., 2010, 138: 133.e131-137.

[20] LöstC. Depth of alveolar bone dehiscences in relation to gingival recessions. J. Clin. Periodontol., 1984, 11: 583-589.

[21] LeeK-M, KimY-I, ParkS-B, SonW-S. Alveolar bone loss around lower incisors during surgical orthodontic treatment in mandibular prognathism. Angle Orthod., 2012, 82: 637-644.

[22] SunL, et al.. Changes of alveolar bone dehiscence and fenestration after augmented corticotomy-assisted orthodontic treatment: a CBCT evaluation. Prog. Orthod., 2019, 20. 7

[23] ZhouH, et al.. The efficacy and safety of corticotomy and periodontally accelerated osteogenic orthodontic interventions in tooth movement: an updated meta-analysis. Head. Face Med., 2024, 2012.

[24] BashutskiJD, et al.. Teriparatide and osseous regeneration in the oral cavity. N. Engl. J. Med., 2010, 363: 2396-2405.

[25] Al-OmariFA, KuroshimaS, UtoY, UchidaY, SawaseT. Effect of intraoral administration of parathyroid hormone on osseous and soft tissue healing around implants in ovariectomized rat maxillae. Clin. Oral. Implants Res., 2024, 35: 305-320.

[26] HaugenHJ, LyngstadaasSP, RossiF, PeraleG. Bone grafts: which is the ideal biomaterial?. J. Clin. Periodontol., 2019, 46: 92-102.

[27] KimCH, et al.. Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment. J. Bone Min. Res., 2003, 18: 2116-2125.

[28] CheongVS, RobertsBC, KadirkamanathanV, Dall’AraE. Positive interactions of mechanical loading and PTH treatments on spatio-temporal bone remodelling. Acta Biomater., 2021, 136: 291-305.

[29] MaycasM, et al.. PTHrP-derived peptides restore bone mass and strength in diabetic mice: additive effect of mechanical loading. J. Bone Min. Res., 2017, 32: 486-497.

[30] MaY, et al.. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. J. Bone Min. Res., 1999, 14: 439-448.

[31] ZhouH, et al.. Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone, 2003, 32: 513-520.

[32] TanakaS, et al.. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells. J. Bone Min. Res., 2004, 19: 1813-1820.

[33] TurnerRT, LotinunS, HefferanTE, Morey-HoltonE. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone. J. Appl. Physiol., 2006, 101: 881-886.

[34] SakaiA, et al.. Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice. J. Bone Min. Res., 1999, 14: 1691-1699.

[35] MyersGE, AndersonJRJr. Nature of contacts in centric occlusion in 32 adults. J. Dent. Res., 1971, 50: 7-13.

[36] RansomRC, et al.. Mechanoresponsive stem cells acquire neural crest fate in jaw regeneration. Nature, 2018, 563: 514-521.

[37] DingY, MoC, GengJ, LiJ, SunY. Identification of periosteal osteogenic progenitors in jawbone. J. Dent. Re.s, 2022, 101: 1101-1109.

[38] GroeneveldtLC, et al.. The bone-forming properties of periosteum-derived cells differ between harvest sites. Front. Cell Dev. Biol., 2020, 8554984.

[39] ChaoM, DonovanT, SoteloC, CarstensMH. In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration. J. Craniofac. Surg., 2006, 17: 405-412.

[40] NakamuraK, et al.. The periosteum provides a stromal defence against cancer invasion into the bone. Nature, 2024, 634: 474-481.

[41] DebnathS, et al.. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature, 2018, 562: 133-139.

[42] Delgado-CalleJ, BellidoT. The osteocyte as a signaling cell. Physiol. Rev., 2022, 102: 379-410.

[43] GaoM, et al.. Distinct differences between calvarial and long bone osteocytes in cell morphologies, gene expression and aging responses. FEBS J., 2023, 290: 4074-4091.

[44] HuangY, LiaoJ, VlashiR, ChenG. Focal adhesion kinase (FAK): its structure, characteristics, and signaling in skeletal system. Cell. Signal., 2023, 111110852.

[45] SunC, et al.. FAK promotes osteoblast progenitor cell proliferation and differentiation by enhancing Wnt signaling. J. Bone Min. Res., 2016, 31: 2227-2238.

[46] QiS, et al.. FAK promotes early osteoprogenitor cell proliferation by enhancing mTORC1 signaling. J. Bone Min. Res., 2020, 35: 1798-1811.

[47] ZhangY, et al.. Extremely low frequency electromagnetic fields promote mesenchymal stem cell migration by increasing intracellular Ca(2+) and activating the FAK/Rho GTPases signaling pathways in vitro. Stem Cell Res. Ther., 2018, 9143.

[48] WardDFJr., et al.. Focal adhesion kinase signaling controls cyclic tensile strain enhanced collagen I-induced osteogenic differentiation of human mesenchymal stem cells. Mol. Cell. Biomech., 2007, 4: 177-188

[49] CalvoN, CarriereP, MartinMJ, GentiliC. RSK activation via ERK modulates human colon cancer cells response to PTHrP. J. Mol. Endocrinol., 2017, 59: 13-27.

[50] HuangDC, et al.. Parathyroid hormone-related protein: potential therapeutic target for melanoma invasion and metastasis. Endocrinology, 2014, 155: 3739-3749.

[51] YukataK, et al.. Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment. Bone, 2014, 62: 79-89.

[52] WangY, et al.. Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling. IUBMB Life, 2021, 73: 213-222.

[53] LvZ, et al.. PTH(1‑34) activates the migration and adhesion of BMSCs through the rictor/mTORC2 pathway. Int J. Mol. Med., 2020, 46: 2089-2101.

[54] KarvandeA, et al.. Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation. Bone, 2018, 117: 98-115.

[55] ZhengW, GuX, SunX, WuQ, DanH. FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells. Artif. Cells Nanomed. Biotechnol., 2019, 47: 2641-2649.

[56] LeeDY, et al.. Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway. J. Biol. Chem., 2010, 285: 30-42.

[57] GentiliC, BolandR, Russo de BolandA. Implication of Gbetagamma proteins and c-SRC tyrosine kinase in parathyroid hormone-induced signal transduction in rat enterocytes. J. Endocrinol., 2006, 188: 69-78.

[58] BouxseinML, et al.. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Min. Res., 2010, 25: 1468-1486.

[59] TsukasakiM, et al.. Periosteal stem cells control growth plate stem cells during postnatal skeletal growth. Nat. Commun., 2022, 13. 4166

[60] van GastelN, et al.. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells, 2012, 30: 2460-2471.

[61] OgitaM, RachedMT, DworakowskiE, BilezikianJP, KousteniS. Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration. Endocrinology, 2008, 149: 5713-5723.

[62] GaoL, et al.. Osteocytes autophagy mediated by mTORC2 activation controls osteoblasts differentiation and osteoclasts activities under mechanical loading. Arch. Biochem. Biophys., 2023, 742109634.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82371003)

Elite Research Grant of International Orthodontics Foundation 2022

RIGHTS & PERMISSIONS

The Author(s)